Machine learning plus optical flow: A simple and sensitive method to detect cardioactive drugs

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lee, Eugene K ^a   Kurokawa, Yosuke K ^b   Tu, Robin ^c   George, Steven C ^b   Khine, Michelle ^a,d  

^a University of California at Irvine   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT;

CARDIAC MUSCLE CELL; DRUG EFFECTS; HEART CONTRACTION; HUMAN; INDUCED PLURIPOTENT STEM CELL; MACHINE LEARNING; OPTICAL INSTRUMENTATION; PHYSIOLOGY;

CARDIOTONIC AGENTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACHINE LEARNING; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; OPTICAL DEVICES;

EID: 84953888876     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11817     Document Type: Article

References (56)

1. Pharmaceutical Research and Manufacturers of America. 2013 Biopharmaceutical Research Industry Profile. 32-33 (2013). at http://www.phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf
2. Shah, R. R. Can pharmacogenetics help rescue drugs withdrawn from the market? Pharmacogenomics 7, 889-908 (2006).
3. Aboumarzouk, O. M., Agarwal, T., Antakia, R., Shariff, U. & Nelson, R. L. Cisapride for intestinal constipation. Cochrane database Syst. Rev. CD007780 (2011). doi: 10.1002/14651858.CD007780.pub2.
4. Dick, E., Rajamohan, D., Ronksley, J. & Denning, C. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem. Soc. Trans. 38, 1037-45 (2010).
5. Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-9 (2011).
6. Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-14 (2001).
7. Robertson, C., Tran, D. D. & George, S. C. Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31, 829-37 (2013).
8. Liang, P. et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals diseasespecific patterns of cardiotoxicity. Circulation 127, 1677-91 (2013).
9. Stoelzle, S. et al. State-of-the-Art Automated Patch Clamp Devices: Heat Activation, Action Potentials, and High Throughput in Ion Channel Screening. Front. Pharmacol. 2, 76 (2011).
10. Malboubi, M. & Jiang, K. in Gigaseal Form. Patch Clamping with Appl. Nanotechnol. (Springer Berlin Heidelberg, 2014). doi: 10.1007/978-3-642-39128-6.
11. Yajuan, X., Xin, L. & Zhiyuan, L. A comparison of the performance and application differences between manual and automated patch-clamp techniques. Curr. Chem. Genomics 6, 87-92 (2012).
12. Herron, T. J., Lee, P. & Jalife, J. Optical imaging of voltage and calcium in cardiac cells & tissues. Circ. Res. 110, 609-23 (2012).
13. Bursac, N., Kirkton, K. R. D., C., M. L. & Liau, B. Characterizing functional stem cell-cardiomyocyte interactions. Regen. Med. 5, 1-29 (2010).
14. McCombs, J. E. & Palmer, A. E. Measuring calcium dynamics in living cells with genetically encodable calcium indicators. Methods 46, 152-9 (2008).
15. Navarrete, E. G. et al. Screening Drug-Induced Arrhythmia Events Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays. Circulation 128, S3-S13 (2013).
16. Clements, M. & Thomas, N. High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays. Toxicol. Sci. 140, 445-61 (2014).
17. Peters, M. F., Lamore, S. D., Guo, L., Scott, C. W. & Kolaja, K. L. Human Stem Cell-Derived Cardiomyocytes in Cellular Impedance Assays: Bringing Cardiotoxicity Screening to the Front Line. Cardiovasc. Toxicol. (2014). doi: 10.1007/s12012-014-9268-9
18. Xi, B. et al. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System. J. Lab. Autom. 16, 415-21 (2011).
19. Chen, A. et al. Integrated platform for functional monitoring of biomimetic heart sheets derived from human pluripotent stem cells. Biomaterials 35, 675-83 (2014).
20. Hather, C., Roquemore, L. & Thomas, N. High-content analysis of a live multiplexed cytotoxicity study using CytivaTM Cardiomyocytes and IN Cell Analyzer 2000. Healthc. Life Sci. Newsl. - Discov. Matters 13, 16-17 (2011).
21. Olsen, C., Hesley, J. & Sirenko, O. High-Throughput Multiparameter. Genet. Eng. Biotechnol. News 33, 36-37 (2013).
22. Soloveva, V., Larocque, J. & Mckillip, E. When Robots Are Good: Fully Automated Thermo LAS Robotic Assay System with Dual FLIPRTETRA and TAP SelecT Robotic Cell Culture System. J. Assoc. Lab. Autom. 11, 145-156 (2006).
23. Okada, Y., Ogawa, S., Sadanaga, T. & Mitamura, H. Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography. J. Am. Coll. Cardiol. 27, 84-9 (1996).
24. Kirsch, G. E. et al. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. J. Pharmacol. Toxicol. Methods 50, 93-101 (2004).
25. Haft, J. I. & Habbab, M. A. Treatment of Atrial Arrhythmias Effectiveness of Verapamil When Preceded by Calcium Infusion. Arch. Intern. Med. 146, 1085-1089 (1986).
26. Bergson, P., Lipkind, G., Lee, S. P., Duban, M.-E. & Hanck, D. A. Verapamil block of T-type calcium channels. Mol. Pharmacol. 79, 411-9 (2011).
27. Mattiazzi, A. & A, G. Negative inotropic effect of verapamil, nifedipine and prenylamine and its reversal by calcium or isoproterenol. Arch. Int. Physiol. Biochem. 91, 133-144 (1983).
28. Kovács, M., Tóth, J., Hetényi, C., Málnási-Csizmadia, A. & Sellers, J. R. Mechanism of blebbistatin inhibition of myosin II. J. Biol. Chem. 279, 35557-63 (2004).
29. Cerignoli, F. et al. High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry. J. Pharmacol. Toxicol. Methods 66, 246-56 (2012).
30. Qian, J.-Y. & Guo, L. Altered cytosolic Ca2+ dynamics in cultured Guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants. Toxicol. In Vitro 24, 960-72 (2010).
31. Sirenko, O. et al. Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells. J. Biomol. Screen. 18, 39-53 (2013).
32. Ke, N., Wang, X., Xu, X. & Abassi, Y. A. in Mamm. Cell Viability (Stoddart, M. J.) 740, 33-43 (Humana Press, 2011).
33. Guo, L. et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 123, 281-9 (2011).
34. Scott, C. W. & Peters, M. F. Label-free whole-cell assays: expanding the scope of GPCR screening. Drug Discov. Today 15, 704-16 (2010).
35. Qiu, Y., Liao, R. & Zhang, X. Impedance-based monitoring of ongoing cardiomyocyte death induced by tumor necrosis factoralpha. Biophys. J. 96, 1985-91 (2009).
36. Nunes, S. S. et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 10, 781-7 (2013).
37. Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101, 18129-34 (2004).
38. Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endodermlike cells. Circulation 107, 2733-40 (2003).
39. Hanjaya-Putra, D. & Gerecht, S. Preview. Mending the failing heart with a vascularized cardiac patch. Cell Stem Cell 5, 575-6 (2009).
40. Kim, C. et al. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev. 19, 783-95 (2010).
41. Zhang, D. et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34, 5813-20 (2013).
42. Schaaf, S. et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 6, e26397 (2011).
43. Grosberg, A., Alford, P. W., McCain, M. L. & Parker, K. K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 11, 4165-73 (2011).
44. Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. Part A 18, 910-9 (2012).
45. Liu, X., Iyengar, S. G. & Rittscher, J. Monitoring cardiomyocyte motion in real time through image registration and time series analysis. IEEE Int. Symp. Biomed. Imaging From Nano to Macro 1308-1311 (2012). doi: 10.1109/ISBI.2012.6235803
46. Hossain, M. M. et al. Non-invasive characterization of mouse embryonic stem cell derived cardiomyocytes based on the intensity variation in digital beating video. Analyst 135, 1624-30 (2010).
47. Ahola, A. et al. Video image-based analysis of single human induced pluripotent stem cell derived cardiomyocyte beating dynamics using digital image correlation. Biomed. Eng. Online 13, 39 (2014).
48. Kim, S. B. et al. A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imaging. Lab Chip 11, 1801-7 (2011).
49. Maddah, M. & Loewke, K. Automated , Non-Invasive Characterization of Stem Cell-Derived Cardiomyocytes from Phase- Contrast Microscopy. Med. Image Comput. Comput. Interv. 17, 57-64 (2014).
50. Hayakawa, T. et al. Noninvasive evaluation of contractile behavior of cardiomyocyte monolayers based on motion vector analysis. Tissue Eng. Part C. Methods 18, 21-32 (2012).
51. Hayakawa, T. et al. Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology. J. Mol. Cell. Cardiol. 77, 178-91 (2014).
52. Huebsch, N. et al. Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem- Derived Cardiomyocytes Cultured over Different Spatial Scales. Tissue Eng. Part C. Methods 21, 1-13 (2014).
53. Maddah, M. et al. A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing. Stem cell reports 4, 621-631 (2015).
54. Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β -catenin signaling under fully defined conditions. Nat. Protoc. 8, 162-75 (2013).
55. Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12, 127-37 (2013).
56. Sun, D., Roth, S. & Black, M. J. Secrets of optical flow estimation and their principles. Proc. IEEE Comput. Soc. Conf. Comput. Vis. Pattern Recognit. 2432-2439 (2010). doi: 10.1109/CVPR.2010.5539939